These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11019654)

  • 1. [Effect of itraconazole on digoxin clearance in patients with congestive heart failure].
    Wakasugi H; Ishizuka R; Koreeda N; Yano I; Futami T; Nohara R; Sasayama S; Inui K
    Yakugaku Zasshi; 2000 Sep; 120(9):807-11. PubMed ID: 11019654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Itraconazole decreases renal clearance of digoxin.
    Jalava KM; Partanen J; Neuvonen PJ
    Ther Drug Monit; 1997 Dec; 19(6):609-13. PubMed ID: 9421099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole increases serum digoxin concentration.
    Partanen J; Jalava KM; Neuvonen PJ
    Pharmacol Toxicol; 1996 Nov; 79(5):274-6. PubMed ID: 8936563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of itraconazole on the pharmacokinetics of digoxin in guinea pigs.
    Nishihara K; Hibino J; Kotaki H; Sawada Y; Iga T
    Biopharm Drug Dispos; 1999 Apr; 20(3):145-9. PubMed ID: 10211867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-itraconazole interaction: possible mechanisms.
    Alderman CP; Allcroft PD
    Ann Pharmacother; 1997 Apr; 31(4):438-40. PubMed ID: 9101006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
    Yukawa E; Suematu F; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y; Aoyama T
    Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population analysis for the optimization of digoxin treatment in Japanese paediatric patients.
    Suematsu F; Minemoto M; Yukawa E; Higuchi S
    J Clin Pharm Ther; 1999 Jun; 24(3):203-8. PubMed ID: 10438180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T
    J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of captopril on serum digoxin levels in patients with severe congestive heart failure.
    Kirimli O; Kalkan S; Guneri S; Tuncok Y; Akdeniz B; Ozdamar M; Guven H
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):311-4. PubMed ID: 11471775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of epoprostenol on drug disposition. I: A pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failure.
    Carlton LD; Patterson JH; Mattson CN; Schmith VD
    J Clin Pharmacol; 1996 Mar; 36(3):247-56. PubMed ID: 8690819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of itraconazole and digoxin.
    Sachs MK; Blanchard LM; Green PJ
    Clin Infect Dis; 1993 Mar; 16(3):400-3. PubMed ID: 8384010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure.
    Harjola VP; Oikarinen L; Toivonen L; Jurkko R; Puttonen J; Sarapohja T; Sundberg S; Nieminen MS
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):389-99. PubMed ID: 18793580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of an interaction between tigecycline and digoxin in healthy men.
    Zimmerman JJ; Harper DM; Matschke K; Speth JL; Raible DG; Fruncillo RJ
    Pharmacotherapy; 2007 Jun; 27(6):835-44. PubMed ID: 17542766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?
    el-Desoky ES; Madabushi R; Amry Sel-D; Bhattaram VA; Derendorf H
    Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment: possible mechanism of digoxin-itraconazole interaction.
    Ito S; Koren G
    Ann Pharmacother; 1997 Sep; 31(9):1091-2. PubMed ID: 9296256
    [No Abstract]   [Full Text] [Related]  

  • 17. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization.
    EL Desoky ES; Nagaraja NV; Derendorf H
    Am J Ther; 2002; 9(6):492-8. PubMed ID: 12424506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on effect of shengmai injection on serum concentration and pharmacokinetic parameters of digoxin in patients with congestive heart failure].
    Mao JY; Xu WR; Wang HH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 May; 23(5):347-50. PubMed ID: 12800416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive performance of four pharmacokinetic methods for calculating digoxin dosage.
    el-Sayed YM
    J Clin Pharm Ther; 1995 Oct; 20(5):297-304. PubMed ID: 8576297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein as the mediator of itraconazole-digoxin interaction.
    Angirasa AK; Koch AZ
    J Am Podiatr Med Assoc; 2002 Sep; 92(8):471-2. PubMed ID: 12237270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.